Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIES (Artificial Intelligence for Endoscopy and Surgery) is a medical technology company specializing in the development of AI-driven diagnostic tools for gastrointestinal procedures. The company's primary focus is on enhancing the accuracy and efficiency of colonoscopies through real-time computer-aided detection (CADe) and computer-aided diagnosis (CADx) of polyps and other abnormalities. By integrating advanced machine learning algorithms with existing endoscopic hardware, AIES aims to reduce the miss rate of precancerous lesions and improve patient outcomes in colorectal cancer screening. Their solutions are designed to provide endoscopists with immediate, data-driven insights during live procedures, streamlining clinical workflows and standardizing the quality of care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIES.